Bridgebio Pharma (BBIO)'s 30-day implied volatility (IV30) was 42.6% at the close on October 28, 2026, down from 44.9% the day before, against a 52-week range of 33.5% to 82.4%. Its 20-day historical volatility was 30.2%.
Data as of October 28, 2026.